Name: Name:N-(tert-Butoxycarbonyl)-L-serine beta-lactone
Brand: AABLOCKS
SKU: AA003SCP
Rating: 90 (10 reviews)

Catalog No.: AA003SCP

98541-64-1 | N-(tert-Butoxycarbonyl)-L-serine beta-lactone

Pack Size： 1g

Purity： 95%

in stock

$39.00 $27.00

Pack Size： 5g

Purity： 95%

in stock

$148.00 $104.00

Pack Size： 100g

Purity： 97%

in stock

$2,204.00 $1,543.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA003SCP

Chemical Name: N-(tert-Butoxycarbonyl)-L-serine beta-lactone

CAS Number: 98541-64-1

Molecular Formula: C8H13NO4

Molecular Weight: 187.1931

MDL Number: MFCD01318414

SMILES: O=C(OC(C)(C)C)N[C@H]1COC1=O

Properties

BP: 319°C at 760 mmHg

Form: Solid

MP: >115°C (dec.)

Refractive Index: -26 ° (C=1, CH3CN)

Storage: Inert atmosphere;-20 ℃;

Complexity: 231

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 1

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 13

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 3

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 0.7

Upstream Synthesis Route

3262-72-4

98541-64-1

[1]BioorganicandMedicinalChemistry,2007,vol.15,#3,p.1330-1340

[2]JournaloftheAmericanChemicalSociety,1985,vol.107,#24,p.7105-7109

[3]Patent:US2010/93720,2010,A1,.Locationinpatent:Page/Pagecolumn37

[4]Heterocycles,2001,vol.55,#1,p.1-4

[5]JournalofMedicinalChemistry,1996,vol.39,#22,p.4430-4438

[6]CanadianJournalofChemistry,1994,vol.72,#4,p.1066-1075

[7]JournaloftheAmericanChemicalSociety,1989,vol.111,#11,p.3973-3976

[8]JournalofOrganicChemistry,2008,vol.73,#2,p.517-521

[9]Patent:CN106083856,2016,A,.Locationinpatent:Paragraph0019;0023;0026

[10]Organicletters,2000,vol.2,#23,p.3603-3606

[11]OrganicandBiomolecularChemistry,2008,vol.6,#20,p.3661-3663

[12]TetrahedronLetters,2006,vol.47,#6,p.1019-1021

[13]EuropeanJournalofOrganicChemistry,2014,vol.2014,#35,p.7806-7809

[14]OrganicSyntheses,1992,vol.70,p.10-10

[15]MedChemComm,2016,vol.7,#11,p.2136-2144

[16]AngewandteChemie,InternationalEdition,2009,vol.48,p.4718-4724

[17]AngewandteChemie,2009,vol.121,p.4812-4818

[18]CanadianJournalofChemistry,1994,vol.72,#4,p.1051-1065

[19]JournalofOrganicChemistry,1996,vol.61,#10,p.3548-3550

[20]EuropeanJournalofOrganicChemistry,2002,#23,p.3995-4004

[21]OrganicandBiomolecularChemistry,2005,vol.3,#6,p.1058-1066

[22]Patent:EP1205471,2002,A1,.Locationinpatent:Page7

[23]Patent:US6953788,2005,B1,.Locationinpatent:Page/Pagecolumn50

[24]JournalofMedicinalChemistry,2010,vol.53,#15,p.5770-5781

[25]JournalofMedicinalChemistry,2012,vol.55,#10,p.4824-4836

[26]AdvancedSynthesisandCatalysis,2016,vol.358,#1,p.34-40

[27]Patent:US9321743,2016,B2,.Locationinpatent:Page/Pagecolumn9

[28]JournalofOrganometallicChemistry,2018,vol.876,p.1-9

[29]Patent:WO2018/167506,2018,A1,.Locationinpatent:Page/Pagecolumn28

3262-72-4

98541-64-1

[1]Patent:US2003/27800,2003,A1,

[2]Patent:US2003/130237,2003,A1,

24424-99-5

98541-64-1

[1]Heterocycles,2001,vol.55,#1,p.1-4

[2]AdvancedSynthesisandCatalysis,2016,vol.358,#1,p.34-40

2766-43-0

98541-64-1

[1]JournalofOrganometallicChemistry,2018,vol.876,p.1-9

98541-64-1

76387-70-7

[1]JournaloftheAmericanChemicalSociety,1985,vol.107,#24,p.7105-7109

Downstream Synthesis Route

288-13-1

98541-64-1

21012-18-0

[1]Patent:US2010/93720,2010,A1.Locationinpatent:Page/Pagecolumn38

[2]JournalofMedicinalChemistry,1993,vol.36,p.449-459

288-32-4

98541-64-1

122225-53-0

[1]Patent:US2010/93720,2010,A1.Locationinpatent:Page/Pagecolumn37

[2]JournalofMedicinalChemistry,1993,vol.36,p.449-459

3756-30-7

98541-64-1

138423-74-2

[1]JournaloftheChemicalSociety.PerkintransactionsI,1991,p.2885-2887

98541-64-1

4392-24-9

138423-73-1

[1]JournaloftheChemicalSociety.PerkintransactionsI,1991,p.2885-2887

98541-64-1

149411-91-6

197011-58-8

[1]AngewandteChemie-InternationalEdition,2018,vol.57,p.14932-14936 Angew.Chem.,2018,vol.130,p.15148-15152,5

[2]OrganicandBiomolecularChemistry,2005,vol.3,p.1058-1066

[3]BioorganicandMedicinalChemistry,2016,vol.24,p.4177-4187

[4]OrganicandBiomolecularChemistry,2008,vol.6,p.3661-3663

Literature fold

Title: N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.

Journal: Journal of medicinal chemistry20120524

Building Blocks More >

530-40-5

N,N-diethylpyridine-4-carboxamide

AA003SH0 | MFCD00059785

893642-00-7

N-Acetyl 2-fluoro-4-(3-hydroxy-3-methylbut-1-ynyl)aniline

AA003SLK | MFCD08701794

15329-69-8

(2E)-4-(Benzylamino)-4-oxobut-2-enoic acid

AA003SPA | MFCD00020482

4515-21-3

N-Carbobenzoxy-dl-aspartic acid

AA003SST | MFCD00063181

957062-74-7

N-Ethyl 2-Bromo-4-trifluoromethoxybenzenesulfonamide

AA003SWE | MFCD09878394

6018-92-4

NICKEL CITRATE

AA003T04 | MFCD03425999

106-52-5

4-Hydroxy-1-methylpiperidine

AA003T47 | MFCD00006500

630-07-9

N-Pentatriacontane

AA003T7W | MFCD00059397

7307-55-3

N-Undecylamine

AA003TBG | MFCD00008152

22006-17-3

o-Toluidine hydrochloride

AA01X3P3 | MFCD00012959